Abstract
Bazal hücreli karsinom (BHK) insanda en sık görülen malign tümördür. Deride herhangi bir yerde görülebilmekle
birlikte, %80’den fazlası baş ve boyun gibi güneşe maruz kalan alanlarda ortaya
çıkmaktadır. Gelişiminde kronik güneş ışığına maruziyet, ana etyolojik faktör
olarak düşünülmektedir. Biz burada; bel
bölgesinde, femur lateral bölgede ve perine bölgesinde olağan dışı yerleşim
gösteren BHK’lı üç olgu sunduk. Hastaların öykülerinde bu bölgelerde BHK
gelişimi açısından etyolojik herhangi bir predizpozan faktöre rastlanmamıştır.
BHK’da metastaz riski çok nadir olmasına rağmen, tümör lokal agresif seyredebilir
ve doku destrüksiyonuna neden olabilir. Bu nedenle; atipik lokalizyonlarda yerleşim gösteren lezyonlarda da BHK akla
gelmesini vurgulamak amacıyla vakalarımız literatür eşliğinde tartışılarak
sunulmaktadır.
References
- Referans1. Mohan SV, Chang AL. Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations. Curr Dermatol Rep. 2014;3(1):40-5
- Referans2. Chang JM, Gao XM. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients. Chin Med J (Engl). 2013;126(2):211-4.
- Referans3. Aldana PC, Yfantis HG, John PR. Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy. Case Rep Dermatol Med. 2019;2019: 6268354.
- Referans4. Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J. Am. Acad. Dermatol. 2019 ; 80(2):303-17.
- Referans5. Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013; 4(1):12-7.
- Referans6. Schlessinger DI, Iyengar S, Yanes AF, Lazaroff JM, Godinez-Puig V, Chen BR. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2017;18(1):490.
- Referans7. Cohen PR. Basal cell carcinoma of the axilla: review of the world literature. Am J Clin Dermatol. 2014;15(2):95-100.
- Referans8. Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540-59.
- Referans9. Pranteda G, Grimaldi M, Lombardi M, Pranteda G, Arcese A, Cortesi G, Muscianese M, Bottoni U.Basal cell carcinoma: differences according to anatomic location and clinical-pathological subtypes.G Ital Dermatol Venereol. 2014 Aug;149(4):423-6.
- Referans10. Narala S, Cohen PR.Basal Cell Carcinoma of the Umbilicus: A Comprehensive Literature Review.Cureus. 2016 ;8(9):770.
- Referans11. Carr AV, Feller E, Zakka FR, Griffith RC, Schechter S. A Case Report of Basal Cell Carcinoma in a Non-Sun-Exposed Area: A Rare Presentation Mimicking Recurrent Perianal Abscess.Case Rep Surg. 2018;2018:9021289.
Abstract
Basal cell carcinoma (BCC)
is the most common malignant tumor in humans. It can be seen anywhere in the
skin, although more than 80% occurs in areas exposed to the sun, such as the
head and neck. Chronic exposure to sunlight is thought to be the
main etiological factor. Although the
risk of metastasis in BCC is very low, the tumor may be locally aggressive and
cause tissue destruction. We present three cases of BCC in atypical
locations, the waist region, the lateral femoral region, and the perineal
region. No predisposing factor in terms
of etiology of BCC was encountered in these patients’ histories. We are
presenting our cases, together with a discussion of the current literature, to
emphasize that BCC should be considered even in atypically located lesions.
References
- Referans1. Mohan SV, Chang AL. Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations. Curr Dermatol Rep. 2014;3(1):40-5
- Referans2. Chang JM, Gao XM. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients. Chin Med J (Engl). 2013;126(2):211-4.
- Referans3. Aldana PC, Yfantis HG, John PR. Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy. Case Rep Dermatol Med. 2019;2019: 6268354.
- Referans4. Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J. Am. Acad. Dermatol. 2019 ; 80(2):303-17.
- Referans5. Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013; 4(1):12-7.
- Referans6. Schlessinger DI, Iyengar S, Yanes AF, Lazaroff JM, Godinez-Puig V, Chen BR. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2017;18(1):490.
- Referans7. Cohen PR. Basal cell carcinoma of the axilla: review of the world literature. Am J Clin Dermatol. 2014;15(2):95-100.
- Referans8. Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540-59.
- Referans9. Pranteda G, Grimaldi M, Lombardi M, Pranteda G, Arcese A, Cortesi G, Muscianese M, Bottoni U.Basal cell carcinoma: differences according to anatomic location and clinical-pathological subtypes.G Ital Dermatol Venereol. 2014 Aug;149(4):423-6.
- Referans10. Narala S, Cohen PR.Basal Cell Carcinoma of the Umbilicus: A Comprehensive Literature Review.Cureus. 2016 ;8(9):770.
- Referans11. Carr AV, Feller E, Zakka FR, Griffith RC, Schechter S. A Case Report of Basal Cell Carcinoma in a Non-Sun-Exposed Area: A Rare Presentation Mimicking Recurrent Perianal Abscess.Case Rep Surg. 2018;2018:9021289.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | OLGU SUNUMU |
| Authors | |
| Publication Date | May 27, 2020 |
| Published in Issue | Year 2020 Volume: 42 Issue: 3 |